HOMEPRODUCTSSERVICESCOMPANYCONTACTFAQResearchDictionaryPharmaMobileSign Up FREE or Login

mapatumumab

a fully human IgG1 agonistic mAb that exclusively targets tumor necrosis factor-related apoptosis-inducing ligand receptor (TRAIL-R1) which is overexpressed on the surface of many tumors
Networked: 34 relevant articles (6 outcomes, 11 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Experts

1. Fox, Norma Lynn: 4 articles (05/2014 - 04/2007)
2. Humphreys, Robin: 4 articles (01/2013 - 02/2009)
3. Kim, Seog-Young: 3 articles (01/2013 - 05/2012)
4. Song, Xinxin: 3 articles (01/2013 - 05/2012)
5. Lee, Yong J: 3 articles (01/2013 - 05/2012)
6. Kakehi, Yoshiyuki: 2 articles (02/2015 - 03/2009)
7. Camidge, D Ross: 2 articles (05/2014 - 09/2009)
8. Cohen, Roger B: 2 articles (09/2009 - 04/2007)
9. Padavic, Kristin: 2 articles (09/2009 - 04/2007)
10. von Mehren, Margaret: 2 articles (09/2009 - 04/2007)

Related Diseases

1. Neoplasms (Cancer)
2. Fever (Fevers)
3. Necrosis
4. Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
5. Ovarian Neoplasms (Ovarian Cancer)

Related Drugs and Biologics

1. TNF-Related Apoptosis-Inducing Ligand Receptors
2. Paclitaxel (Taxol)
3. Carboplatin (JM8)
4. Caspases
5. PRO 95780
6. rituximab (Mabthera)
7. lexatumumab
8. Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
9. oxaliplatin (Eloxatin)
10. Antibodies

Related Therapies and Procedures

1. Drug Therapy (Chemotherapy)
2. Heterologous Transplantation (Xenotransplantation)
3. Drug-Eluting Stents
4. Stents